Skip to main content
. Author manuscript; available in PMC: 2018 Apr 10.
Published in final edited form as: Psychopharmacology (Berl). 2017 Oct 10;235(1):135–143. doi: 10.1007/s00213-017-4750-2

Table 1.

Mean VI response rate, DRO resets and infusions (+/− SEM) under VI and DRO schedule for Males and Females treated with Progesterone (PRO) or Vehicle (VEH)

VI 30-s (Go phase) DRO 30-s (No-go phase)
Sex Treatment (n) Condition Resp. Rate (r/m) Inf. DRO resets Inf.
Male VEH (n = 8) Baseline 0.54 (0.15) 17.79 (2.34) 16.54 (6.16) 21.83 (0.45)
Tx 0.63 (0.21) 18.58 (3.57) 19.75 (11.87) 22.13 (0.56)
PRO (n=8) Baseline 0.51 (0.09) 22.33 (3.40) 37.71 (23.27) 20.13 (1.67)
Tx 0.51 (0.15) 19.58 (4.05) 29.87 (16.41) 19.79 (1.71)
Female VEH (n=7) Baseline 15.12 (13.81) 46.19 (18.24) 47.10 (34.60) 20.67 (1.46)
Tx 17.78 (16.72) 49.14 (20.44) 57.24 (30.10) 18.86 (1.17)
PRO (n=7) Baseline 0.84 (0.28) 35.76 (9.29) 16.48 (5.30) 19.29 (1.78)
Tx 0.75 (0.34) 29.76 (9.67) 9.19 (2.72) 21.71 (0.87)